iShares iBonds Dec 2026 Term Corporate ETF (IBDR) ETF Price & AI Analysis

$24.12
0.08%
Bloomberg December 2026 Maturity Corpora…
| Bonds – Corporate
February 16, 12:53 AM EST
  • Assets Under Management
    $3.21B
  • Volume
    $303,048
  • Expense
    0.1000%
  • 52W Range
    23.61 - 24.68
  • Return 1Y
    5%
  • Return 3Y
    1.51%
  • Return 5Y
    1.44%
  • Prev. Close
    $24.10
  • SMA 20
    0.01%
  • SMA 50
    0.12%
  • SMA 200
    0.40%
  • RSI (14)
    54
  • Beta
    0.22
  • ATR (14)
    0.04
  • Perf Week
    0.17%
  • Perf Month
    0.12%
  • Perf 6 Months
    0.08%
  • Perf Year
    0%
  • Perf YTD
    0.21%

About iShares iBonds Dec 2026 Term Corporate ETF

iShares iBonds Dec 2026 Term Corporate ETF seeks to track the investment results of the Bloomberg December 2026 Maturity Corporate Index composed of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2026. The fund will invest at least 80% of its assets in the component instruments of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index. The index consists of U.S. dollar-denominated, investment-grade securities publicly issued by U.S. and non-U.S. corporate issuers that have $300 million or more of outstanding face value at the time of inclusion.

iShares iBonds Dec 2026 Term Corporate ETF | Latest news

Q1 2024 Cytek Biosciences Inc Earnings Call

Participants Paul Goodson; Investor Relations; Cytek Biosciences Wenbin Jiang; Chairman of the Board, President, Chief Executive Officer, Co-Founder; Cytek Biosciences Inc William Mccombe; Chief ...

Thomson Reuters StreetEvents - 9 months ago